ResearchMoz

Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-08-30
No. Of Pages » 84
This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019).

The report also contains a section on market overview which consists of a detailed qualitative analysis of various market dynamics, such as drivers, restraints and opportunities. A section on market attractiveness analysis and Porter’s five force analysis for the companion diagnostics market has also been included.

Market share analysis of the leading players operating in the companion diagnostics market, in terms of % share for the year 2012, has been presented in the competitive landscape. The report also includes the list of recommendations for new market entrants. Some of the key market players profiled in this report include Roche Holdings AG, Abbott Laboratories, Genomic Health, Inc., Qiagen N.V., Life Technologies Corporation, Agilent Technologies, Inc. and GE Healthcare, Ltd.

The global companion diagnostics market is segmented into the following categories:

Companion Diagnostics Market, by Indications
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Other (HIV, Thalassemia)

Companion Diagnostics Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 List Of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Rising Need For Companion Diagnostics Along With Targeted Therapies
3.2.2 Increasing Demand As Well As Developmental Efforts Towards Personalized Medicine
3.2.3 The Pharmacoeconomic Advantage: Reduced Drug Development Costs
3.2.4 Increasing Cancer Incidence Worldwide
3.2.5 Impact Analysis Of Market Drivers
3.3 Market Restraints
3.3.1 Effect Of Influence Of Advocacy Groups And Clinical Societies
3.3.2 Prolonged Developmental And Approval Phases
3.3.3 Impact Analysis Of Market Restraints
3.4 Market Opportunities
3.4.1 Expansion Into Newer Indication Areas
3.5 Porter’s Five Force Analysis: Global Companion Diagnostics Market
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat Of Substitutes
3.5.4 Threat Of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, By Geography, 2012

Chapter 4 Companion Diagnostics Market, By Indications, 2011 - 2019 (USD Million)
4.1 Introduction
4.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Indication, 2012 & 2019 (Value %)
4.1.2 Breast Cancer
4.1.3 Lung Cancer
4.1.4 Colorectal Cancer
4.1.5 Gastric Cancer
4.1.6 Melanoma
4.1.7 Others (HIV, Thalassemia)

Chapter 5 Companion Diagnostics Market, By Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Companion Diagnostics Market Size And Forecast, 2011 - 2019 (Usd Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.5 Rest Of The World (Row)
5.5.1 Row Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Market Share By Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Changing Business Models of Pharmaceutical and Diagnostics Manufacturers
7.2 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agendia N.V.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.2.4 Recent Developments
8.3 Agilent Technologies, Inc.,
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Biogenex Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.4.4 Recent Developments
8.5 Ge Healthcare Ltd.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Genomic Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Laboratory Corporation Of America Holdings (Labcorp)
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Qiagen N.V.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Resonance Health Analysis Services Pty Ltd.
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Business Strategies
8.10.4 Recent Developments
8.11 Roche Holdings Ag
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Siemens Healthcare
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments

List of Tables


TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Companion Diagnostics Market
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Companion Diagnostics Market, by Indications, Size and Forecast, 2011 - 2019 (USD Million)
TABLE 6 Global Companion Diagnostics Market, by Geography, Size and Forecast, 2011 - 2019 (USD Million)

List of Figures


FIG. 1 Companion Diagnostics Market Segmentation
FIG. 2 Global Companion Diagnostics Market, by Indication, 2012 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Companion Diagnostics Market
FIG. 4 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012
FIG. 5 Comparative Analysis: Global Companion Diagnostics Market, by Indications, 2012 & 2019 (Value %)
FIG. 6 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 7 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 8 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 9 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 10 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 11 Global Other Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 12 Comparative Analysis: Global Companion Diagnostics Market, by Geography, 2012 & 2019 (Value %)
FIG. 13 North American Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 14 European Market for Companion Diagnostics, Size and Forecast, 2011– 2019 (USD Million)
FIG. 15 Asia-Pacific Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 16 RoW Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 17 Market Share Analysis: Companion Diagnostics Market, 2012 (%)
FIG. 18 Annual Revenues: Abbott Laboratories,  2010–2012 (USD Million)
FIG. 19 Annual Revenues: Agilent Technologies, Inc., 2010–2012 (USD Million)
FIG. 20 Annual Revenues: GE Healthcare, 2010–2012 (USD Million)
FIG. 21 Annual Revenues: Genomic Health, Inc.,  2010–2012 (USD Million)
FIG. 22 Annual Revenues: LabCorp,  2010–2012 (USD Million)
FIG. 23 Annual Revenues: Life Technologies Corporation, 2010–2012 (USD Million)
FIG. 24 Annual Sales: Qiagen N.V., 2010–2012 (USD Million)
FIG. 25 Annual Revenues: Roche Holdings AG, 2010–2012 (USD Million) (1Swiss Franc = 1.09 USD) (USD Million)
FIG. 26 Annual Revenues: Siemens Healthcare, 2010–2012 (USD Million)

Upcoming Reports:

Cognitive Assessment And Training Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Cognitive assessment and training is a formal assessment of one’s psychological functions and speed of information processing. This method of assessment helps an individual in assessing, defining and focusing on individual needs more efficiently. The analysis after cognitive assessment can be useful for various functions such as cognitive training of individuals, early detection of dementia among population and sports management. Based on the statistics provided by Alzheimer's Disease International, approximately 44.4 million people are suffering from dementia worldwide, as of 2013;...
Biomass Market - Global Industry Analysis, Size, Share, Trends, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Biomass is a resource for renewable energy. It is derived from principal resources such as forestry, biogenic waste and agricultural products. Energy is created from biomass or by converting it into products such as other bio fuels. The electricity can be generated by direct combustion or by converting biomass into fiber or industrial chemical. Since the economics is improved for energy production by biomass, and also there is growing concerns about greenhouse gas emissions, biomass energy is becoming an increasingly attractive option. Biomass is the unique renewable source of energy which...
Biosensors Market - (Resonant Mirror, Electrochemical, Surface Plasmon Resonance, Light Addressable Potentiometric) - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Biosensors are the devices used for the detection of analyte and combines physiological detector with biological components. There are certain types of biosensors that include resonant mirror, electrochemical, surface plasmon resonance and light addressable potentiometric.The biosensors market is expected to witness the growth owning to wide range of applications in cardiac monitoring, diabetes monitoring, agriculture, drug recovery, environmental practices and others.  Biosensors market is segmented into three aspects include- by applications, technologies and end use...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Microsoft to Complete Nokia Purchase by April 25
Apr 23, 2014  
The Microsoft-Nokia deal that made headlines when it was announced is finally on its way to being completed. This proves that even the most complex deals do culminate with time. This week, Microsoft announced that it would complete the purchase of a major part of Nokia’s hardware assets by Friday. The much discussed deal-though on the brink of completion-has witnessed some adjustments...
Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...